Look For Institutional Buying In Vertex Pharmaceuticals, Inc (NASDAQ: VRTX)
Vertex Pharmaceuticals, Inc (VRTX) concluded trading on Thursday at a closing price of $396.64, with 8.2 million shares of worth about $3.25 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.38% during that period and on December 19, 2024 the price saw a […]
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) – Suitable For Long Term Buy?
Currently, there are 257.70M common shares owned by the public and among those 256.81M shares have been available to trade. Insiders at the company have transacted a total of 198 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 11 of these insider trades were purchases, […]
